Lead Product(s): Genetically modified Vaccinia virus Copenhagen
Therapeutic Area: Oncology Product Name: VVcopTK-RR-
Highest Development Status: Undisclosed Product Type: Undisclosed
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 08, 2021
VVcopTK-RRis a large capacity Vaccinia virus Copenhagen strain genetically modified with the double deletion TK-RR- which restricts the viral replication to tumor cells only.
Lead Product(s): Tedopi,Undisclosed
Therapeutic Area: Oncology Product Name: OSE-2101
Highest Development Status: Undisclosed Product Type: Vaccine
Partner/Sponsor/Collaborator: European Investment Bank
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 15, 2021
This loan will help expand the clinical development of Tedopi® in combination with a checkpoint inhibitor in additional cancer indications.